NVTC recently hosted the first-ever Capital Health Tech Summit on June 15, 2017 at the Inova Center for Personalized Health. The fascinating field of pharmacogenomics, the study of how genes affect a person’s response to medications, was covered by an expert panel.
Pharmacogenomics panelists included Translational Software Chief Science Officer Dr. Houda Hachad, Inova Center for Personalized Health Assistant Vice President of Personalized Health Franziska Moeckel and CGI Chief Architect and Corporate Ambassador, Global Health IT Practice, Stephen Saunders. Inova Translational Medicine Institute Chief Operating Officer Dr. John Deeken moderated.
- Pharmacogenomics is putting data in patients’ hands, empowering them to live healthier lives
- Pharmacogenomics has significant implications for reducing long-term healthcare costs and improving long-term health outcomes.
- According to panelists, 8% of all ER visits are because of drug reactions; pharmacogenomics can help reduce these visits and the medical costs associated with them considerably.
- Pharmacogenomics mapping, starting as early as maternity, can help ensure patients are receiving the most personalized, impactful care over their lifetimes.
- The translational software fueling pharmacogenomics today is the missing bridge between laboratories and hospitals and doctors’ offices.
View the full video from the panel below to learn more: